Abstract 1572P
Background
The determinants of choices of orientation towards medical oncology have been little explored.
Methods
Medical students of the classes 2022 and 2023 in Lille and Amiens Universities (North of France) were enrolled in a quantitative online survey, with 2 follow-up over 2 months. 36 potential determinants from previous works (Wright et al. 2004; Beaulieu et al. 2010) were evaluated using a 5-point Likert scale alongside parameters. Choosing oncology was assessed among 44 specialities. We identified determinants using both CHAID method and binary and multiple linear regressions, and CHAID method.
Results
Responders were 563 (563/1250; 45%). CHAID analysis retained 2 factors: “medical oncology traineeship” (p<.0001) and “identification with a doctor in the specialty” (p=.049). when excluding factors associated with énd-cycle trining, CHAID analysis retained 2 factors associated with a career choice in oncology: “rejection of emergency care” (p=.036) and “wish of hospital-university career” (p=.006). Motivations differed according to sexes. In men, choosing oncology was associated in multivariate analysis with: “hospital traineeship in medical oncology” (β=0.22; p=.010), “hospital traineeship in oncology radiotherapy” (β=0.22; p<0.001) and “interest in fundamental research” (β=0.06; p<.001). Conversely, “rural life” (β=-0.09; p=.014) was negatively associated with this choice. In women, parameters positively associated with choosing oncology were: “hospital traineeship in medical oncology” (β=0.289; p<.001), “long-term relationship with patients” (β=0.12; p=.021) and “hospital work” (β=0.21; p=0<.001). A negative association was observed for: “treatment with visible outcome in the short term” (β=-0.15; p=.018) and “rural life” (β=-0.15; p=.006).
Conclusions
Motivations varied according to sexes. Hospital experience during the second cycle of medical studies plays a determining role. The ability or the interest in emergency management seems important in career choice. Certain interests influence career choice (long-term relationship with patient) as well as contextual factors (rural life). These results can be interpreted according to Bandura's social cognitive theory.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Centre Oscar Lambret.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1199P - Developing and systematically validating homologous recombination repair gene detection method based on next-generation sequencing
Presenter: Yi Sun
Session: Poster session 10
1200P - Investigation of multiphoton microscopy as an innovative tool for intraoperative section-free histologic investigations in just a few minutes
Presenter: Martí Homs Soler
Session: Poster session 10
1201P - Novel deep learning model and validation of whole slide images in lung cancer diagnosis
Presenter: Alhassan Ahmed
Session: Poster session 10
Resources:
Abstract
1202P - A deep learning approach using routine pathology images to guide precision medicine in metastatic CRC
Presenter: Chaitanya Parmar
Session: Poster session 10
1203P - Analytical evaluation of whole genome sequencing for acute myeloid leukemia
Presenter: Guidantonio Malagoli Tagliazucchi
Session: Poster session 10
1204P - Real-world utility of whole genome sequencing for patients with cancer: Evaluation of a regional implementation of the 100,000 genomes project
Presenter: Helen Robbins
Session: Poster session 10
1205P - A retrospective machine learning-based analysis of nationwide cancer CGP data across cancer types to identify features associated with recommendation of mutation-based therapy
Presenter: Hiroaki Ikushima
Session: Poster session 10
1478P - Dual single-nucleotide polymorphism biomarker combination to select opioid for cancer pain management
Presenter: Yoshihiko Fujita
Session: Poster session 10
1479P - Use of rescue opioids and pain control after ketamine initiation in refractory cancer pain: A multicentric observational study
Presenter: Pablo Gallardo Melo
Session: Poster session 10
1480P - Long term therapy with denosumab and zoledronic acid: A comparative real-world retrospective observational study on skeletal-related events and pain in patients with metastatic breast cancer
Presenter: Giacomo Massa
Session: Poster session 10